The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma

Citation

Coulson, R, Liew, S, Connelly, A et al 2017, 'The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma', Oncotarget, vol. 8, no. 12, pp. 18640-18656pp.

Year

2017

ANU Authors

Fields of Research

  • Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)
  • Cancer Cell Biology
  • Molecular Targets

Updated:  22 January 2020 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers